别名:SEC14-like protein 4, Tocopherol-associated protein 3, SEC14L4, TAP3应用:WB,IHC
反应种属:Human
规格:50μl/100μl
| Description |
|---|
| The protein encoded by this gene is highly similar to the protein encoded by the Saccharomyces cerevisiae SEC14 gene. The SEC14 protein is a phophatidylinositol transfer protein that is essential for biogenesis of Golgi-derived transport vesicles, and thus is required for the export of yeast secretory proteins from the Golgi complex. The specific function of this protein has not yet been determined. Alternative splicing results in multiple transcript variants. |
| Specification | |
|---|---|
| Aliases | SEC14-like protein 4, Tocopherol-associated protein 3, SEC14L4, TAP3 |
| Entrez GeneID | 284904 |
| Swissprot | Q9UDX3 |
| WB Predicted band size | 46.6kDa |
| Host/Isotype | Rabbit IgG |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | This SEC14L4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 41-70 amino acids from the N-terminal region of human SEC14L4. |
| Formulation | Purified polyclonal antibody supplied in PBS with 0.05% sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
| Application | |
|---|---|
| WB | 1/1000 |
| IHC | 1/100-1/500 |
![]() |
SEC14L4 Antibody (N-term) (Cat. #P31252) western blot analysis in K562 cell line lysates (35ug/lane).This demonstrates the SEC14L4 antibody detected the SEC14L4 protein (arrow). |
![]() |
SEC14L4 Antibody (N-term) (Cat. #P31252)immunohistochemistry analysis in formalin fixed and paraffin embedded human liver tissue followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of SEC14L4 Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated. |
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的,不可用于人类或动物的临床诊断或治疗,非药用,非食用。
暂无评论
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的,不可用于人类或动物的临床诊断或治疗,非药用,非食用。
中文


发表回复